GKOS
- Glaukos Corporation
()
Overview
Company Summary
Glaukos Corporation (GKOS) is a medical technology company that specializes in developing and commercializing innovative surgical devices and therapies for the treatment of glaucoma, a chronic eye disease that can lead to vision loss if left untreated.
The company's flagship product is the iStent, a tiny implantable device that is used during cataract surgery to improve the eye's natural outflow pathway, which helps reduce intraocular pressure (IOP) caused by glaucoma. The iStent is the first and only FDA-approved device for this purpose, and it has been proven to effectively lower IOP and reduce the need for glaucoma medications in patients.
In addition to the iStent, Glaukos offers various other products that focus on providing minimally invasive treatment options for glaucoma patients. These include the iStent inject, iStent supra, and iDose implants, which are designed to further enhance the surgical outcomes for patients with different types and severities of glaucoma.
Glaukos is committed to advancing the field of ophthalmology and improving patient outcomes by continuously investing in research and development. The company also provides training and education to healthcare professionals to ensure proper utilization and optimal outcomes for its products.
Overall, Glaukos Corporation's mission is to develop innovative technologies that provide safe and effective treatment options for patients with glaucoma, ultimately improving their quality of life by preserving their vision.